Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Lancet Oncol. 2018 May;19(5):694-704. doi: 10.1016/S1470-2045(18)30148-7. Epub 2018 Apr 5.
Lancet Oncol. 2018.
PMID: 29628312
Free PMC article.
Clinical Trial.
Phase II trial of combined modality therapy with myeloid growth factor support in patients with locally advanced non-small cell lung cancer.
Lilenbaum R, Samuels M, Taffaro-Neskey M, Cusnir M, Pizzolato J, Blaustein A.
Lilenbaum R, et al. Among authors: taffaro neskey m.
J Thorac Oncol. 2010 Jun;5(6):837-40. doi: 10.1097/JTO.0b013e3181d6e141.
J Thorac Oncol. 2010.
PMID: 20421820
Free article.
Clinical Trial.
Item in Clipboard
Lung cancer: screening, staging, targeted therapies.
Taffaro-Neskey M.
Taffaro-Neskey M.
JAAPA. 2011 Dec;24(12):65, 70. doi: 10.1097/01720610-201112000-00011.
JAAPA. 2011.
PMID: 22315919
No abstract available.
Item in Clipboard
Case of the month. Bleomycin-induced lung injury.
Taffaro-Neskey M.
Taffaro-Neskey M.
JAAPA. 2009 May;22(5):76. doi: 10.1097/01720610-200905000-00019.
JAAPA. 2009.
PMID: 19469397
No abstract available.
Item in Clipboard
Cite
Cite